130 results about "Potential candidate" patented technology

A method of language recognition wherein decoding ambiguities are identified and at least partially resolved intermediate to the language decoding procedures to reduce the subsequent number of final decoding alternatives. The user is questioned about identified decoding ambiguities as they are being decoded. There are two language decoding levels: fast match and detailed match. During the fast match decoding level a large potential candidate list is generated, very quickly. Then, during the more comprehensive (and slower) detailed match decoding level, the fast match candidate list is applied to the ambiguity to reduce the potential selections for final recognition. During the detailed match decoding level a unique candidate is selected for decoding. Decoding may be interactive and, as each ambiguity is encountered, recognition suspended to present questions to the user that will discriminate between potential response classes. Thus, recognition performance and accuracy is improved by interrupting recognition, intermediate to the decoding process, and allowing the user to select appropriate response classes to narrow the number of final decoding alternatives.

This invention relates to a low cost rapid response diagnostic system to determine cortisol levels in patients selected as potential candidates for GCR (glucocorticoid receptor) antagonist therapy utilizing a GCR antagonist, such as ORG 34517. The rapid, sensitive, and inexpensive test can be used to determine patients who have non-normal cortisol production or disordered circadian rhythms as a method for selecting subjects for GCR antagonist therapy for whom it is likely to have beneficial and / or therapeutic effects, and can also be used to monitor changes in cortisol levels in response to treatment.

A validation phase is performed at an RFID reader, in order to ascertain which of a plurality of potential candidates for authentication, are actual candidates for authentication. Once a candidate has been successfully validated, an authentication phase is initiated with a host computer, to determine whether the information presented by the candidate matches expected information about the candidate. If the authentication is considered successful, a final authorization procedure may be performed, or the authenticated candidate may be granted certain predetermined permissions. By performing the validation phase locally at the reader, the need for accessing a host computer is reduced and unnecessary queries to the host computer are avoided.

Identifying the information associated with a number of different user accounts may provide the basis for automatically generating a chat session based on that information. In one example method of operation a number of users may be identified as potential candidates for a chat session via an automated agent application and an attribute of each of the users may be retrieved from memory that shares a common interest identifier with the other users. The chat session can then be created based on the common interest identifier, and a notification can be transmitted to each of the users to invite them to the chat session.

A music searching system and method conducting a metadata search of music based on an entered search term. Music identified from the metadata search is used as seed music to identify other acoustically complementing music. Acoustic analysis data of the seed music is compared against acoustic analysis data of potential candidates for determining whether they are acoustically complementing music. The acoustically complementing music is then displayed to the user for listening, downloading, or purchase.

The present invention is based on the findings that BACE2, a homolog of β-secretase BACE, is able to stimulate processing of APP in a non-amyloidogenic pathway, thereby suppressing the level of Aβ. Accordingly, the present invention provides methods and means for the identification and use of modulators of this unique activity of BACE2 to suppress Aβ production. The compounds identified using the methods and means provided herein may be used as potential candidates for the treatment of Alzheimer's disease and other neurological diseases.